Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityNo recent work listed

Dan Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-9605-918X; OpenAlex author ID A5100380696. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of P… Co-author DOI 10.7150/jca.69617↗
  2. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy. Co-author DOI 10.7150/thno.22834↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. She Tian · 1 shared paper, 2022 · strength 0.20
  2. Chengyi Sun · 1 shared paper, 2022 · strength 0.20
  3. Yuting Guo · 1 shared paper, 2022 · strength 0.20
  4. Lianfang Du · 1 shared paper, 2018 · strength 0.08
  5. Xiangyang Shi · 1 shared paper, 2018 · strength 0.08
  6. Feng Gao · 1 shared paper, 2018 · strength 0.08
  7. Peng Qin · 1 shared paper, 2018 · strength 0.08
  8. Lizhou Lin · 1 shared paper, 2018 · strength 0.08
  9. Fan Li · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.